Neurokinin receptors. the role of substance P in inflammatory processes
Hrabec, Z.; Hrabec, E.
Postepy Biochemii 38(1): 28-32
1992
ISSN/ISBN: 0032-5422 PMID: 1380702 Document Number: 398468
Document emailed within 1 workday
Related Documents
Sun, Y.-M.; Luo, S.-J.; Zhao, Y.-H. 2006: Substance P regulates function of osteoclasts via neurokinin-1 receptor Hua Xi Kou Qiang Yi Xue Za Zhi 24(1): 60-62Saijo, A.; Ishii, Y.; Kitamura, S. 1996: Effects of substance P and neurokinin a on pulmonary circulation in the isolated perfused guinea pig lung Nihon Kyobu Shikkan Gakkai Zasshi 34(1): 16-23
Tiurenkov, I.N.; Perfilova, V.N. 2011: Role of GABA receptors in pathological processes Eksperimental'naia i Klinicheskaia Farmakologiia 74(2): 47-52
Wang, Z.-L.; Hao, L.-Y.; Zhao, M.-L.; Xia, X.-C.; Bai, X.-G.; Zhang, J.-F.; Huang, Y.-P.; Huang, S.-S.; Li, Z.-Y.; Zheng, X.-H. 2019: Correlation of behavioral performance with expressions of substance P and neurokinin-1 receptor in the L5－S2 spinal cord of chronic prostatitis rats Zhonghua Nan Ke Xue 25(6): 489-495
Goode, T.; O'Connell, J.; Sternini, C.; Anton, P.; Wong, H.; O'Sullivan, G.C.; Collins, J.K.; Shanahan, F. 1998: Substance P (neurokinin-1) receptor is a marker of human mucosal but not peripheral mononuclear cells: molecular quantitation and localization Journal of Immunology 161(5): 2232-2240
Cecha, J.ós.; Drabek, G.; Błazelonis, A.; Romanowski, W.; Zubelewicz-Szkodzińska, B. 2004: The role of HMG-CoA reductase inhibitors in regulation of the inflammatory processes Wiadomosci Lekarskie 57(5-6): 255-258
Crowther, R.; Jukic, D.; Regoli, D.; Rangachari, P.K. 1994: Functional subtyping of neurokinin receptors on canine proximal colonic mucosa Journal of Pharmacology and Experimental Therapeutics 268(3): 1374-1380
Jacob, C.; Martin-Chouly, C.; Lagente, V. 2002: Type 4 phosphodiesterase-dependent pathways: role in inflammatory processes Therapie 57(2): 163-168
Ciobanu, V.; Zălaru, M. 1972: Role of soluble immune complexes in pathogenesis of some inflammatory processes Medicina Interna 24(7): 793-802
Miyayasu, K.; Mak, J.C.; Nishikawa, M.; Barnes, P.J. 1993: Characterization of guinea pig pulmonary neurokinin type 1 receptors using a novel antagonist ligand, [3H]FK888 Molecular Pharmacology 44(3): 539-544
Cornelius, C.P.; Ehrenfeld, M.; Dannenmaier, B.; Stern, W. 1988: Topographic anatomy of tooth germs and maxillary sinus, and their role in inflammatory processes of the maxilla Deutsche Zahnarztliche Zeitschrift 43(12): 1255-1258
Krawczyk-Michalak, K.; Glapiński, A.; Brzezińska-Błaszczyk, E. 2008: Toll-like receptors and their role in regulation of the inflammatory response in sepsis Anestezjologia Intensywna Terapia 40(4): 253-259
Kosyakova, Y.A.; Kondurtsev, V.A.; Davydkin, I.L.; Zorenko, V.Y. 2015: The Role of the Combination of Inflammatory Processes in the Joints and Altered Regional Microcirculation in the Development of Hemophilic Arthropathy Klinicheskaia Meditsina 93(4): 52-56
Priĭma, O.B. 1992: The role of hypoxia and non-enzyme cationic proteins of leukocytes in the pathogenesis of acute post-operative purulent-inflammatory processes Klinicheskaia Khirurgiia 6: 60-63
Weisel, M. 1976: Indications and contraindications for roentgen irradiation of inflammatory and degenerative processes. Radiophobia in irradiation of inflammatory and degenerative processes Zeitschrift für Arztliche Fortbildung 70(15): 774-777
Tvarůzková, Z.; Pavlová, S.ár.; Doubek, M.; Mayer, J.í; Pospísilová, S.ár. 2011: Lymphoproliferative disease in patients with autoimmune and inflammatory diseases: significance of antigenic stimulation and inflammatory processes Casopis Lekaru Ceskych 150(3): 161-168
Patacchini, R.; Quartara, L.; Rovero, P.; Goso, C.; Maggi, C.A. 1993: Role of C-terminal amidation on the biological activity of neurokinin A derivatives with agonist and antagonist properties Journal of Pharmacology and Experimental Therapeutics 264(1): 17-21
Whitesell, N.Rumbaugh.; Beals, J.; Mitchell, C.M.; Manson, S.M.; Turner, R.Jay.; Big Crow, C.K.; Buchwald, D.; Chambers, B.; Christensen, M.L.; Dillard, D.A.; DuBray, K.; Espinoza, P.A.; Fleming, C.M.; Wilson Frederick, A.; Gone, J.; Gurley, D.; Jervis, L.L.; Jim, S.M.; Kaufman, C.E.; Klein, S.A.; Lee, D.; Manson, S.M.; McNulty, M.C.; Middlebrook, D.L.; Moore, L.A.; Nez, T.D.; Norton, I.M.; Novins, D.K.; O'Nell, T.; Orton, H.D.; Randall, C.J.; Sam, A.; Shore, J.H.; Simpson, S.G.; Yazzie, L. 2009: Childhood exposure to adversity and risk of substance-use disorder in two American Indian populations: the meditational role of early substance-use initiation Journal of studies on alcohol and drugs 70(6): 971-981
Okamoto, Y.; Shirotori, K.; Kudo, K.; Ishikawa, K.; Ito, E.; Togawa, K.; Saito, I. 1993: Cytokine expression after the topical administration of substance P to human nasal mucosa. the role of substance P in nasal allergy Journal of Immunology 151(8): 4391-4398
De, A.K.; Ghosh, J.J. 1990: Inflammatory responses induced by substance P in rat paw Indian Journal of Experimental Biology 28(10): 946-948